Back to Search
Start Over
Ketamine increases vmPFC activity: Effects of (R)- and (S)-stereoisomers and (2R,6R)-hydroxynorketamine metabolite.
- Source :
-
Neuropharmacology [Neuropharmacology] 2020 Apr; Vol. 166, pp. 107947. Date of Electronic Publication: 2020 Jan 09. - Publication Year :
- 2020
-
Abstract
- Ketamine, an NMDA receptor antagonist and fast acting antidepressant, produces a rapid burst of glutamate in the ventral medial prefrontal cortex (mPFC). Preclinical studies have demonstrated that pyramidal cell activity in the vmPFC is necessary for the rapid antidepressant response to ketamine in rodents. We sought to characterize the effects of ketamine and its stereoisomers (R and S), as well as a metabolite, (2R,6R)-hydroxynorketamine (HNK), on vmPFC activity using a genetically encoded calcium indicator (GCaMP6f). Ratiometric fiber photometry was utilized to monitor GCaMP6f fluorescence in pyramidal cells of mouse vmPFC prior to and immediately following administration of compounds. GCaMP6f signal was assessed to determine correspondance of activity between compounds. We observed dose dependent effects with (R,S)-ketamine (3-100 mg/kg), with the greatest effects on GCaMP6f activity at 30 mg/kg and lasting up to 20 min. (S)-ketamine (15 mg/kg), which has high affinity for the NMDA receptor channel produced similar effects to (R,S)-ketamine, but compounds with low NMDA receptor affinity, including (R)-ketamine (15 mg/kg) and (2R,6R)-HNK (30 mg/kg) had little or no effect on GCaMP6f activity. The initial response to administration of (R,S)-ketamine as well as (S)-ketamine is characterized by a brief period of robust GCaMP6f activation, consistent with increased activity of vmPFC pyramidal neurons. Because (2R,6R)-HNK and (R)-ketamine are reported to have antidepressant activity in rodent models the current results indicate that different initiating mechanisms lead to similar brain adaptive consequences that underlie the rapid antidepressant responses.<br />Competing Interests: Declaration of competing interest We declare that Dr. Duman has consulted and/or received research support from Naurex, Aptynx, Lilly, Relmada, Navitor, Johnson & Johnson, Taisho, and Sunovion. The remaining authors have no competing financial interests.<br /> (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Subjects :
- Animals
Dose-Response Relationship, Drug
Excitatory Amino Acid Antagonists chemistry
Excitatory Amino Acid Antagonists metabolism
Ketamine chemistry
Ketamine metabolism
Male
Mice
Mice, Inbred C57BL
Mice, Transgenic
Photometry methods
Prefrontal Cortex drug effects
Stereoisomerism
Excitatory Amino Acid Antagonists pharmacology
Ketamine analogs & derivatives
Ketamine pharmacology
Prefrontal Cortex metabolism
Subjects
Details
- Language :
- English
- ISSN :
- 1873-7064
- Volume :
- 166
- Database :
- MEDLINE
- Journal :
- Neuropharmacology
- Publication Type :
- Academic Journal
- Accession number :
- 31926944
- Full Text :
- https://doi.org/10.1016/j.neuropharm.2020.107947